The first partner company is on the path to market, but the implications are clear: eXoZymes has created a scalable production engine for molecules that were previously too rare or expensive to make.

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...

LOS ANGELES, CALIFORNIA / ACCESS Newswire / December 11, 2025 /Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of ...

African lemongrass is known to aid digestion by stimulating the production of digestive enzymes. This can help alleviate ...

Establishment of commercial-scale manufacturing for plant-based Vitamin D3, a breakthrough innovation for which Fermenta has recently received process patent protection in India.

Dyadic Applied BioSolutions ('Dyadic”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, ...

Subject to TSX Venture Exchange (“ TSXV ”) approval, NurExone has engaged Russo Partners LLC, a New York–based strategic ...

By designing a squaric acid amide that binds a new site on ATP synthase, researchers created PRP020, a potential therapy for ...

Finnish researchers unveil Sweeprot, a next-generation sweet protein derived from brazzein, offering zero-calorie, sugar-like ...

The latest update is out from eXoZymes ( (EXOZ) ).